Addition of Sorafenib to Chemotherapy Improves the Overall Survival of Older Adults With FLT3-ITD Mutated AML (Alliance C11001).
- Citation:
- Blood vol 126 (23) 319
- Meeting Instance:
- ASH 2015
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2562
- Pharmas:
- Grants:
- Corr. Author:
- Geoffrey L. Uy
- Authors:
- Geoffrey L. Uy Sumithra Mandrekar Kristina Laumann Ben Sanford Guido Marcucci Weiqiang Zhao Mark Levis Heidi D. Klepin Bayard L. Powell Maria R. Baer Wendy Stock John Byrd Richard M. Stone Richard A. Larson
- Networks:
- CA043, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NY158, LAPS-OH007, MD015, NC002, OH070
- Study
- CALGB-11001
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: